This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wizel, B.
Right arrow Articles by Tarleton, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wizel, B.
Right arrow Articles by Tarleton, R. L.

 Previous Article  |  Next Article 

Infection and Immunity, November 1998, p. 5073-5081, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Vaccination with Trypomastigote Surface Antigen 1-Encoding Plasmid DNA Confers Protection against Lethal Trypanosoma cruzi Infection

Benjamin Wizel, Nisha Garg, and Rick L. Tarleton*

Department of Cellular Biology, University of Georgia, Athens, Georgia 30602

Received 7 May 1998/Returned for modification 23 July 1998/Accepted 10 August 1998

DNA vaccination was evaluated with the experimental murine model of Trypanosoma cruzi infection as a means to induce antiparasite protective immunity, and the trypomastigote surface antigen 1 (TSA-1), a target of anti-T. cruzi antibody and major histocompatibility complex (MHC) class I-restricted CD8+ cytotoxic T-lymphocyte (CTL) responses, was used as the model antigen. Following the intramuscular immunization of H-2b and H-2d mice with a plasmid DNA encoding an N-terminally truncated TSA-1 lacking or containing the C-terminal nonapeptide tandem repeats, the antibody level, CTL response, and protection against challenge with T. cruzi were assessed. In H-2b mice, antiparasite antibodies were induced only by immunization with the DNA construct encoding TSA-1 containing the C-terminal repeats. However, both DNA constructs were efficient in eliciting long-lasting CTL responses against the protective H-2Kb-restricted TSA-1515-522 epitope. In H-2d mice, inoculation with either of the two TSA-1-expressing vectors effectively generated antiparasite antibodies and primed CTLs that lysed T. cruzi-infected cells in an antigen-specific, MHC class I-restricted, and CD8+-T-cell-dependent manner. When TSA-1 DNA-vaccinated animals were challenged with T. cruzi, 14 of 22 (64%) H-2b and 16 of 18 (89%) H-2d mice survived the infection. The ability to induce significant murine anti-T. cruzi protective immunity by immunization with plasmid DNA expressing TSA-1 provides the basis for the application of this technology in the design of optimal DNA multicomponent anti-T. cruzi vaccines which may ultimately be used for the prevention or treatment of Chagas' disease.


* Corresponding author. Mailing address: University of Georgia, Department of Cellular Biology, 724 Biological Sciences Building, Athens, GA 30602. Phone: (706) 542-3362. Fax: (706) 542-4271. E-mail: tarleton{at}cb.uga.edu.


Infection and Immunity, November 1998, p. 5073-5081, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Silveira, E. L. V., Claser, C., Haolla, F. A. B., Zanella, L. G., Rodrigues, M. M. (2008). Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease. CVI 15: 1292-1300 [Abstract] [Full Text]  
  • Cazorla, S. I., Becker, P. D., Frank, F. M., Ebensen, T., Sartori, M. J., Corral, R. S., Malchiodi, E. L., Guzman, C. A. (2008). Oral Vaccination with Salmonella enterica as a Cruzipain-DNA Delivery System Confers Protective Immunity against Trypanosoma cruzi. Infect. Immun. 76: 324-333 [Abstract] [Full Text]  
  • Hoft, D. F., Eickhoff, C. S., Giddings, O. K., Vasconcelos, J. R. C., Rodrigues, M. M. (2007). Trans-Sialidase Recombinant Protein Mixed with CpG Motif-Containing Oligodeoxynucleotide Induces Protective Mucosal and Systemic Trypanosoma cruzi Immunity Involving CD8+ CTL and B Cell-Mediated Cross-Priming. J. Immunol. 179: 6889-6900 [Abstract] [Full Text]  
  • Giddings, O. K., Eickhoff, C. S., Smith, T. J., Bryant, L. A., Hoft, D. F. (2006). Anatomical Route of Invasion and Protective Mucosal Immunity in Trypanosoma cruzi Conjunctival Infection.. Infect. Immun. 74: 5549-5560 [Abstract] [Full Text]  
  • Miyahira, Y., Takashima, Y., Kobayashi, S., Matsumoto, Y., Takeuchi, T., Ohyanagi-Hara, M., Yoshida, A., Ohwada, A., Akiba, H., Yagita, H., Okumura, K., Ogawa, H. (2005). Immune Responses against a Single CD8+-T-Cell Epitope Induced by Virus Vector Vaccination Can Successfully Control Trypanosoma cruzi Infection. Infect. Immun. 73: 7356-7365 [Abstract] [Full Text]  
  • Araujo, A. F. S., de Alencar, B. C. G., Vasconcelos, J. R. C., Hiyane, M. I., Marinho, C. R. F., Penido, M. L. O., Boscardin, S. B., Hoft, D. F., Gazzinelli, R. T., Rodrigues, M. M. (2005). CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2. Infect. Immun. 73: 6017-6025 [Abstract] [Full Text]  
  • Martin, D. L., Tarleton, R. L. (2005). Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection. J. Immunol. 174: 1594-1601 [Abstract] [Full Text]  
  • Lieke, T., Graefe, S. E. B., Klauenberg, U., Fleischer, B., Jacobs, T. (2004). NK Cells Contribute to the Control of Trypanosoma cruzi Infection by Killing Free Parasites by Perforin-Independent Mechanisms. Infect. Immun. 72: 6817-6825 [Abstract] [Full Text]  
  • Bhatia, V., Sinha, M., Luxon, B., Garg, N. (2004). Utility of the Trypanosoma cruzi Sequence Database for Identification of Potential Vaccine Candidates by In Silico and In Vitro Screening. Infect. Immun. 72: 6245-6254 [Abstract] [Full Text]  
  • Agusti, R., Paris, G., Ratier, L., Frasch, A. C.C., de Lederkremer, R. M. (2004). Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo. Glycobiology 14: 659-670 [Abstract] [Full Text]  
  • Dumonteil, E., Escobedo-Ortegon, J., Reyes-Rodriguez, N., Arjona-Torres, A., Ramirez-Sierra, M. J. (2004). Immunotherapy of Trypanosoma cruzi Infection with DNA Vaccines in Mice. Infect. Immun. 72: 46-53 [Abstract] [Full Text]  
  • Boscardin, S. B., Kinoshita, S. S., Fujimura, A. E., Rodrigues, M. M. (2003). Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection. Infect. Immun. 71: 2744-2757 [Abstract] [Full Text]  
  • Garg, N., Tarleton, R. L. (2002). Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection. Infect. Immun. 70: 5547-5555 [Abstract] [Full Text]  
  • Katae, M., Miyahira, Y., Takeda, K., Matsuda, H., Yagita, H., Okumura, K., Takeuchi, T., Kamiyama, T., Ohwada, A., Fukuchi, Y., Aoki, T. (2002). Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy. Infect. Immun. 70: 4833-4840 [Abstract] [Full Text]  
  • Ouaissi, A., Guilvard, E., Delneste, Y., Caron, G., Magistrelli, G., Herbault, N., Thieblemont, N., Jeannin, P. (2002). The Trypanosoma cruzi Tc52-Released Protein Induces Human Dendritic Cell Maturation, Signals Via Toll-Like Receptor 2, and Confers Protection Against Lethal Infection. J. Immunol. 168: 6366-6374 [Abstract] [Full Text]  
  • Planelles, L., Thomas, M. C., Alonso, C., Lopez, M. C. (2001). DNA Immunization with Trypanosoma cruzi HSP70 Fused to the KMP11 Protein Elicits a Cytotoxic and Humoral Immune Response against the Antigen and Leads to Protection. Infect. Immun. 69: 6558-6563 [Abstract] [Full Text]  
  • Fujimura, A. E., Kinoshita, S. S., Pereira-Chioccola, V. L., Rodrigues, M. M. (2001). DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene. Infect. Immun. 69: 5477-5486 [Abstract] [Full Text]  
  • Kumar, S., Tarleton, R. L. (2001). Antigen-Specific Th1 But Not Th2 Cells Provide Protection from Lethal Trypanosoma cruzi Infection in Mice. J. Immunol. 166: 4596-4603 [Abstract] [Full Text]  
  • Sepulveda, P., Hontebeyrie, M., Liegeard, P., Mascilli, A., Norris, K. A. (2000). DNA-Based Immunization with Trypanosoma cruzi Complement Regulatory Protein Elicits Complement Lytic Antibodies and Confers Protection against Trypanosoma cruzi Infection. Infect. Immun. 68: 4986-4991 [Abstract] [Full Text]  
  • Quanquin, N. M., Galaviz, C., Fouts, D. L., Wrightsman, R. A., Manning, J. E. (1999). Immunization of Mice with a TolA-Like Surface Protein of Trypanosoma cruzi Generates CD4+ T-Cell-Dependent Parasiticidal Activity. Infect. Immun. 67: 4603-4612 [Abstract] [Full Text]  
  • Rodrigues, M. M., Ribeirao, M., Pereira-Chioccola, V., Renia, L., Costa, F. (1999). Predominance of CD4 Th1 and CD8 Tc1 Cells Revealed by Characterization of the Cellular Immune Response Generated by Immunization with a DNA Vaccine Containing a Trypanosoma cruzi Gene. Infect. Immun. 67: 3855-3863 [Abstract] [Full Text]